Running whole genome sequencing (WGS) in-house offers greater control over workflows, faster iteration cycles, and direct access to sequencing infrastructure. More organizations are investing in internal sequencing capabilities to support translational research, biomarker discovery, and large-scale genomics programs.
However, the true operational cost of managing in-house WGS extends far beyond sequencing reagents and instrument access. Hidden expenses can add up as projects scale, making outsourcing an attractive, scalable alternative for some organizations.
In this article, we walk through 10 commonly underestimated cost drivers for in-house WGS, and explore when outsourcing to a sequencing provider may offer a scalable alternative.
A sequencing service provider has the benefit of multiple ongoing projects at any one time. This allows them to maximize their throughput and maintain, on average, higher instrument utilization across multiple projects. If you’re running sequencing projects for individual research projects, you may experience instruments sitting idle between runs or difficulty batching samples effectively.
When instrument throughput is inconsistent, your actual cost per genome increases.
Library preparation is often treated as a fixed per-sample cost. However, variability in sample quality, prep efficiency, and QC outcomes can introduce substantial downstream expenses. Failed or inconsistent libraries may require repeat preparation, resequencing, and additional bioinformatics review, increasing both turnaround time and operational burden.
Lab automation systems can significantly reduce the impacts of human variability. However, adding those systems to your lab is another large up-front cost. Specialized providers may already have optimized, validated workflows that reduce process variability at scale.
With in-house genome sequencing comes in-house bioinformatics or analysis systems. Bioinformatics pipeline management is a full-time job, whether in the initial building stages or managing upkeep and updates. The hidden effort required to engineer those systems, validate them, and debug them can eat into your time and budget.
While sequencing costs per genome have declined, the downstream burden of storing and managing WGS data continues to grow. A single human whole genome sequenced at 30x coverage can generate 100-250 GB of compressed FASTQ data. Large-scale projects may accumulate hundreds of terabytes annually.
Beyond storage itself, labs must account for backup redundancy, data transfer infrastructure, long-term retention policies, and the computational resources required to access and analyze these datasets efficiently.
WGS datasets are not only expensive to generate, they can also be difficult to move efficiently between instruments, storage environments, bioinformatics teams, and external collaborators. As projects scale, laboratories may encounter network limitations, slow transfer speeds, duplicated datasets, and cloud egress fees that delay downstream analysis workflows.
In multi-site research programs, transferring large FASTQ, BAM, or CRAM files between institutions and cloud platforms can introduce operational friction that affects turnaround time, collaboration efficiency, and overall project scalability.
Established sequencing service providers often have this infrastructure built already, and can manage storage infrastructure and secure data delivery within a centralized workflow.
Resequencing costs are rarely included in your upfront project estimates. Issues like coverage gaps, sample contamination, or low sample quality can add unexpected steps to your workflow. In some cases, laboratories may need to perform repeat library preparation, supplemental sequencing, or additional bioinformatics review to recover usable data.
These rework cycles can increase reagent consumption, extend turnaround times, and reduce overall sequencing efficiency, especially in high-throughput or clinically sensitive workflows.
Specialized sequencing providers may offer standardized QC checkpoints, validated library preparation workflows, and extensive experience managing diverse sample types at scale.
Managing whole genome sequencing workflows in-house often requires expertise across molecular biology, sequencing operations, bioinformatics, data infrastructure, and quality management. As WGS programs scale, laboratories may find that staffing needs extend well beyond instrument operation alone.
Recruiting and retaining experienced bioinformatics personnel, pipeline engineers, laboratory informatics specialists, and QC-focused sequencing staff can be both costly and time-intensive. In addition, evolving sequencing technologies and analysis workflows require ongoing training, workflow validation, and cross-functional coordination to maintain consistent performance.
For organizations with fluctuating project volumes or limited internal genomics infrastructure, maintaining this breadth of specialized expertise can become a significant long-term operational challenge.
Laboratories often require sophisticated informatics infrastructure to manage sample tracking, metadata organization, workflow coordination, QC documentation, and downstream reporting. While smaller projects may initially rely on spreadsheets or manual workflows, these approaches can become difficult to maintain as sequencing volume and project complexity increase.
Implementing and maintaining laboratory information management systems (LIMS), workflow automation tools, and integrated reporting platforms may introduce substantial hidden operational costs. This often includes software customization, instrument integration, user training, validation, and ongoing system maintenance. Like QC processes and data transfer systems, a service provider will often have a sophisticated LIMS in place.
Working with clinical or regulated projects? Maintaining CLIA and CAP compliance is a time-consuming add-on. The accreditation process involves extensive documentation, assay validation, proficiency testing, audits, and ongoing quality management to stay compliant.
As sequencing workflows evolve, laboratories may also need to continuously review and update standard operating procedures (SOPs), validation protocols, personnel training records, and quality control documentation. These requirements can consume significant staff time and administrative resources, particularly for growing genomics programs balancing research, clinical, and operational priorities.
For organizations without dedicated quality and regulatory teams, maintaining long-term compliance infrastructure can become a major hidden cost of in-house whole genome sequencing operations.
While sequencing instruments themselves may operate quickly, delays often emerge elsewhere in the workflow. Sample queueing, library preparation, QC review, data processing, and bioinformatics analysis can impact your timeline.
For laboratories managing time-sensitive translational or clinical research programs, maintaining consistent and predictable sequencing timelines can become a significant operational challenge.
Sometimes, handling your whole genome sequencing in-house will make sense. Likely, this would mean that you’re working with:
High, consistent sample volume
Established infrastructure and staff
A need for rapid iteration or method development
However, if you find yourself working with:
Inconsistent or project-based demand
Limited bioinformatics resources
Strict compliance requirements
A need for predictable turnaround time or cost
…then outsourcing to a service partner may be the way to go.